BioSpace News Archive

Novan, Inc., announced its financial and operating results for the full year ended December 31, 2022 and provided a corporate update.

Valneva SE, a specialty vaccine company, announced it will present on its single-shot chikungunya vaccine candidate, VLA1553, and host a roundtable on Zika vaccines next week at the 23rd World Vaccine Congress in Washington, D.C.

Addex Therapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, reported financial results for the full-year ended December 31, 2022, and provided a corporate update.

Galderma will be presenting the latest data from the Sculptra® Cheek Wrinkle and Alluzience® STAR studies at the 21st Aesthetic & Anti-Aging Medical World Congress, taking place in Monaco, from March 30 to April 1, 2023.

Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, has announced receiving the market authorization of the U.S. Food and Drug Administration for its pioneering RemeOs™ trauma screw to be used for healing of bone fractures aligned with the clinical trial.

Molecure S.A. a clinical stage biotechnology company that uses its world leading medicinal chemistry and biology capabilities to discover and develop first-in-class small molecule drug candidates that directly modulate unexplored protein and RNA targets to treat multiple incurable diseases, announces full year results for the period ended 31 December 2022.

Poolbeg Pharma Plc a leading biopharmaceutical company focusing on infectious and prevalent diseases with a high unmet medical need, is pleased to announce its audited results for the year ended 31 December 2022.

Selvita S.A. one of the largest CRO companies in Europe has published a full-year report for 2022.

On March 29, 2023, Zylox-Tonbridge Medical Technology Co., Ltd. released its annual financial results for 2022.

NRG Therapeutics, Ltd., an innovative neuroscience company targeting mitochondrial dysfunction, is pleased to announce the formation of its scientific advisory board, to support and steer its R&D programmes to develop novel small molecule therapies for the treatment of neurodegenerative disorders.